Nalamachu SR - Search Results

1

Development of federally mandated risk evaluation and mitigation strategies (REMS) for transmucosal immediate-release fentanyl products.

Pergolizzi JV, Gharibo CG, Gudin JA, Nalamachu SR. Pergolizzi JV, et al. Among authors: nalamachu sr. Pain Pract. 2013 Apr;13(4):259-63. doi: 10.1111/papr.12040. Epub 2013 Mar 6. Pain Pract. 2013. PMID: 23464790 Free PMC article. No abstract available.

2

A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P. Pergolizzi JV Jr, et al. Pain Pract. 2013 Mar;13(3):239-52. doi: 10.1111/j.1533-2500.2012.00578.x. Epub 2012 Jun 21. Pain Pract. 2013. PMID: 22716295 Review.

3

Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.

Nalamachu SR, Pergolizzi J, Taylor R Jr, Slatkin NE, Barrett AC, Yu J, Bortey E, Paterson C, Forbes WP. Nalamachu SR, et al. Pain Pract. 2015 Jul;15(6):564-71. doi: 10.1111/papr.12218. Epub 2014 May 10. Pain Pract. 2015. PMID: 24815199 Clinical Trial.

4

An overview of prodrug technology and its application for developing abuse-deterrent opioids.

Gudin JA, Nalamachu SR. Gudin JA, et al. Among authors: nalamachu sr. Postgrad Med. 2016 Jan;128(1):97-105. doi: 10.1080/00325481.2016.1126186. Epub 2015 Dec 18. Postgrad Med. 2016. PMID: 26615852 Review.

5

Opioid Related Endocrinopathy.

Gudin JA, Laitman A, Nalamachu S. Gudin JA, et al. Pain Med. 2015 Oct;16 Suppl 1:S9-15. doi: 10.1111/pme.12926. Pain Med. 2015. PMID: 26461076 Review.

6

Evolution to low-dose NSAID therapy.

Pergolizzi JV Jr, Raffa RB, Nalamachu S, Taylor R Jr. Pergolizzi JV Jr, et al. Pain Manag. 2016 Apr;6(2):175-89. doi: 10.2217/pmt.15.69. Epub 2016 Mar 16. Pain Manag. 2016. PMID: 26980438 Review.

7

Levorphanol use: past, present and future.

Gudin J, Fudin J, Nalamachu S. Gudin J, et al. Postgrad Med. 2016 Jan;128(1):46-53. doi: 10.1080/00325481.2016.1128308. Epub 2015 Dec 27. Postgrad Med. 2016. PMID: 26635068 Review.

8

Characteristics of Analgesic Patch Formulations.

Nalamachu S, Gudin J. Nalamachu S, et al. J Pain Res. 2020 Sep 22;13:2343-2354. doi: 10.2147/JPR.S270169. eCollection 2020. J Pain Res. 2020. PMID: 33061549 Free PMC article. Review.

9

Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives.

Pergolizzi JV Jr, Taylor R Jr, Nalamachu S, Raffa RB, Carlson DR, Varanasi RK, Kopecky EA. Pergolizzi JV Jr, et al. Curr Med Res Opin. 2014 Feb;30(2):191-202. doi: 10.1185/03007995.2013.854197. Epub 2013 Oct 28. Curr Med Res Opin. 2014. PMID: 24117419

10

Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies.

Raffa RB, Taylor R Jr, Pergolizzi JV Jr, Nalamachu S, Edwards ES, Edwards ET. Raffa RB, et al. Drug Deliv Transl Res. 2017 Feb;7(1):1-10. doi: 10.1007/s13346-016-0323-x. Drug Deliv Transl Res. 2017. PMID: 27562292 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page